https://www.benzinga.com/markets/cannabis/21/05/21345081/psyched-nasdaq-gets-its-third-psychedelics-company-mynd-goes-public-delic-buys-new-research-faci
https://www.benzinga.com/markets/cannabis/21/05/21261079/another-psychedelics-company-joins-exclusive-nasdaq-group-with-enverics-acquisition-of-magicmed-
MagicMed to Be Acquired by Nasdaq-Listed Company
Enveric Biosciences Buys MagicMed In All Stock Deal Valued At $30 Million [The Green Market Journal]
https://www.greenmarketreport.com/enveric-biosciences-buys-magicmed-in-all-stock-deal-valued-at-30-million/
MagicMed: Finding the Derivative with Dr. Joseph Tucker
https://psychedelicspotlight.com/enveric-biosciences-acquires-magicmed-industries/
(NASDAQ:ENVB) Enveric Moves to Acquire MagicMed, Form Latest Nasdaq-Listed Psychedelics Company
Enveric Biosciences Buys MagicMed In All Inventory Deal Valued At $30 Million
https://www.cancernetwork.com/view/oncology-peer-review-on-the-go-1-on-1-with-david-johnson-enveric-s-endocannabinoid-products-for-glioblastoma
https://fortune.com/2021/04/13/happy-employees-happy-shareholders/